Bd reports first quarter fiscal 2024 financial results

Margin execution drives better performance in quarter and higher guidance for fiscal 2024 q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic q1 gaap and adjusted diluted eps from continuing operations of $0.96 and $2.68, respectively company raises full-year adjusted eps guidance and midpoint of organic revenue growth guidance franklin lakes, n.j. , feb. 1, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its first quarter of fiscal 2024, which ended december 31, 2023.
BDX Ratings Summary
BDX Quant Ranking